GH1 and Failure to thrive: TKI drugs can impact multiple hormone levels by interfering with several endocrine gland axes, leading to disrupted pituitary function and potential deficiencies in growth hormone and insulin-like growth factors, ultimately resulting in failure to thrive [20,21].